Disseminated Intravascular Coagulation (DIC) Market Insights 2025-2034: Growth Dynamics, Trends, and Strategic Opportunities
Get 20% off on Global Market Reports until March 31st! Use code FY25SAVE at checkout.
What key factors are powering the surge in the disseminated intravascular coagulation (dic) market right now?
The market size for disseminated intravascular coagulation (DIC) has experienced substantial growth in the past few years. The market is predicted to expand from $0.46 billion in 2024 to $0.49 billion in 2025, with a compound annual growth rate (CAGR) of 5.3%. This growth in the historical period is due to factors such as an increase in sepsis prevalence, a rise in trauma cases, an upsurge in cancer occurrences, an increase in healthcare spending, greater awareness among healthcare professionals, and increased adoption of targeted therapies.
How fast Is the disseminated intravascular coagulation (dic) market expected to grow, and what’s its future value?
The market for disseminated intravascular coagulation (DIC) is projected to experience substantial growth in the coming years. By 2029, it is expected to reach a value of $0.59 billion, growing at a compound annual growth rate (CAGR) of 5.0%. This growth can be linked to several factors such as the increasing use of targeted therapies, heightened emphasis on early detection of diseases, an increase in healthcare infrastructure investments, increased clinical research into coagulopathy treatments, and a rise in awareness about uncommon blood disorders. Key trends for this forecast period include the advancement of diagnostic tests, the uptake of new anticoagulant therapies, personalized medicinal approaches, AI integration in diagnostics, improved patient monitoring platforms, and the creation of targeted treatments.
Get your disseminated intravascular coagulation (dic) market report here!
What are the leading drivers of growth in the disseminated intravascular coagulation (dic) market?
The growth of the disseminated intravascular coagulation (DIC) market is anticipated to be propelled by the rising incidence of cancer. This disease, marked by abnormal cells’ unregulated growth and spread, can infest and destroy healthy tissues. Increasing prominence of cancer links back to factors like aging, lifestyle shifts, environmental exposure, infections, and genetic susceptibility. Tumor-produced procoagulant substances can instigate excessive activation of the coagulation cascade in cancer, causing disseminated intravascular coagulation (DIC) through broad clotting and bleeding. For example, the National Cancer Institute reported in May 2024 that around 20 million fresh cancer diagnoses and almost 9.7 million cancer-related fatalities were documented globally in 2022. These numbers are estimated to increase up to 29.9 million new instances and 15.3 million fatalities annually by 2040. Consequently, cancer’s rising prevalence is accelerating the disseminated intravascular coagulation (DIC) market’s growth.
What are the key segments defining the disseminated intravascular coagulation (dic) market?
The disseminated intravascular coagulation (DIC) market covered in this report is segmented –
1) By Treatment: Medicines, Transfusions, Surgery, Other Treatments
2) By Diagnosis: Complete Blood Count With Blood Smear Exam, Partial Thromboplastin Time (PTT), Fibrinogen Blood Test, D-dimer, Other Diagnoses
3) By Route Of Administration: Oral, Parenteral, Other Routes Of Administration
4) By Distribution Channel: Hospital Pharmacy, Retail Pharmacy, Online Pharmacy
5) By End-Users: Hospitals, Specialty Clinics, Homecare, Other End-Users
Subsegments:
1) By Medicines: Anticoagulants, Antiplatelet Drugs, Fibrinolytics, Procoagulants, Antithrombin Therapy
2) By Transfusions: Platelet Transfusion, Fresh Frozen Plasma (FFP), Cryoprecipitate Transfusion, Red Blood Cell Transfusion
3) By Surgery: Surgical Removal Of Thrombus, Organ Surgery
4) By Other Treatments: Plasma Exchange, Supportive Care, Steroid Therapy
Get your free sample now – explore exclusive market insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=21172&type=smp
Who are the key players steering the development of the disseminated intravascular coagulation (dic) market?
Major companies operating in the disseminated intravascular coagulation (DIC) market are Nihon Kohden Corporation, Pfizer Inc., Johnson & Johnson, F. Hoffmann-La Roche Ltd., AbbVie Inc., Merck & Co. Inc., Bayer AG, Sanofi S.A., AstraZeneca plc, Abbott Laboratories, Novartis AG, Thermo Fisher Scientific Inc., Fresenius Kabi AG, GlaxoSmithKline plc, Danaher Corporation, Eli Lily and Company, Siemens Healthineers, Teva Pharmaceutical Industries Ltd., Mylan N.V., Grifols S.A., Eisai Co. Ltd., Beckman Coulter Inc., Sysmex Corporation, Bio-Rad Laboratories Inc.
What emerging trends are influencing the growth of the disseminated intravascular coagulation (dic) market?
Leading firms in the disseminated intravascular coagulation (DIC) market are concentrating on innovation in coagulation diagnostic techniques, including state-of-the-art blood clotting tests, to make the diagnosis of DIC faster, easier, and more precise, thus enabling quicker interventions and better patient results. Advanced blood clotting exams, or next-generation tests, include sophisticated diagnostic tools and procedures developed to assess blood coagulation in a more precise, efficient, and extensive manner than conventional testing methods. For example, in June 2022, UK-based healthcare firm LumiraDx Limited amplified its cardiovascular testing offerings with CE Mark approvals for its NT-proBNP and revised D-Dimer tests. These tests augment the LumiraDx Platform’s functionality in assisting clinicians in the diagnosis of heart failure and the exclusion of venous thromboembolism at the point of care. Such advancements are geared towards improving early detection and handling of cardiovascular and thrombotic conditions, including disseminated intravascular coagulation (DIC).
Unlock exclusive market insights – purchase your research report now for a swift delivery!
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=21172
Which regions are most influential in expanding the disseminated intravascular coagulation (dic) market?
North America was the largest region in the disseminated intravascular coagulation (DIC) market in 2024. The regions covered in the disseminated intravascular coagulation (DIC) market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Browse Through More Similar Reports By The Business Research Company:
Severe Acute Respiratory-Syndrome Treatment Global Market Report 2025
Myelodysplastic Syndrome (MDS) Drugs Global Market Report 2025
Hospital-Acquired Infection Control Global Market Report 2025
About The Business Research Company:
With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.
Contact us at:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 3156230293
Asia +44 2071930708
Europe +44 2071930708
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
Found this article helpful? Share it on:
